[allAfrica] Lima, Peru — Africa is contributing to groundbreaking data from the PURPOSE 2 study, which explores twice-yearly lenacapavir for HIV prevention. This study, with participants from South Africa and Uganda , is one of the scientific highlights showcased at the 5th HIV Research for Prevention Conference, better known as HIVR4P 2024, in Lima, Peru.
Source link : https://allafrica.com/stories/202410080190.html
Author :
Publish date : 2024-10-08 10:00:43
Copyright for syndicated content belongs to the linked Source.